Form 4: Agilon Health Director John William Wulf Reports Stock Transactions
SEC Form 4 Filing
Director John William Wulf reports acquisition and disposal of Agilon Health (AGL) common stock and restricted stock units.
Summary
- On May 29, 2024, John William Wulf, a director of Agilon Health, Inc. (AGL), reported transactions involving the company's common stock.
- Wulf acquired 32,119 shares of common stock.
- Wulf also disposed of 161,133 shares.
- Following these transactions, Wulf beneficially owns 161,133 shares, including restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common practice for publicly traded companies.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of stock acquisition and disposal. |
| 05/29/2025 | Vesting date for restricted stock units. |
| 05/31/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.